Dr. med. Daniel Weilenmann
chief of service
Kardiologie · Dept. I
Pleural effusion in severe aortic stenosis: marker of an adverse haemodynamic constellation and poor prognosis.
Breuss A, Porsch M, Aschmann A, Weber L, Appert S, Haager P, Weilenmann D, Wildermuth S, Rickli H, Maeder M. Pleural effusion in severe aortic stenosis: marker of an adverse haemodynamic constellation and poor prognosis. ESC Heart Fail 2024
Jan 10, 2024Pleural effusion in severe aortic stenosis: marker of an adverse haemodynamic constellation and poor prognosis.
Jan 10, 2024ESC Heart Fail 2024
Breuss Alexander, Porsch Maximilian, Aschmann André, Weber Lukas, Appert Sharon, Haager Philipp K., Weilenmann Daniel, Wildermuth Simon, Rickli Hans, Maeder Micha
Pulmonary and Systemic Hemodynamics in Patients with Hyperthyroidism.
Brenner R, Drescher T, Locher R, Bilz S, Rickli H, Brändle M, Nobel D, Weilenmann D, Ammann P, Maeder M. Pulmonary and Systemic Hemodynamics in Patients with Hyperthyroidism. Am J Med 2023
Dec 15, 2023Pulmonary and Systemic Hemodynamics in Patients with Hyperthyroidism.
Dec 15, 2023Am J Med 2023
Brenner Roman, Drescher Tilman, Locher Rebecca, Bilz Stefan, Rickli Hans, Brändle Michael, Nobel Daniel, Weilenmann Daniel, Ammann Peter, Maeder Micha
Pulmonary Congestion by Conventional Chest Radiography: Relationship With Hemodynamics and Mortality in Patients With Severe Aortic Stenosis.
Breuss A, Aschmann A, Porsch M, Weber L, Appert S, Haager P, Weilenmann D, Wildermuth S, Rickli H, Maeder M. Pulmonary Congestion by Conventional Chest Radiography: Relationship With Hemodynamics and Mortality in Patients With Severe Aortic Stenosis. CJC Open 2023; 5:938-946.
Sep 21, 2023Pulmonary Congestion by Conventional Chest Radiography: Relationship With Hemodynamics and Mortality in Patients With Severe Aortic Stenosis.
Sep 21, 2023CJC Open 2023; 5:938-946
Breuss Alexander, Aschmann André, Porsch Maximilian, Weber Lukas, Appert Sharon, Haager Philipp K., Weilenmann Daniel, Wildermuth Simon, Rickli Hans, Maeder Micha
Sex-specific inequalities in the use of drug-coated balloons for small coronary artery disease: a report from the BASKET-SMALL 2 trial.
Rubini Gimenez M, Scheller B, Farah A, Ohlow M, Mangner N, Weilenmann D, Wöhrle J, Cuculi F, Leibundgut G, Möbius-Winkler S, Cattaneo M, Gilgen N, Kaiser C, Jeger R. Sex-specific inequalities in the use of drug-coated balloons for small coronary artery disease: a report from the BASKET-SMALL 2 trial. Clin Res Cardiol 2023
Jul 26, 2023Sex-specific inequalities in the use of drug-coated balloons for small coronary artery disease: a report from the BASKET-SMALL 2 trial.
Jul 26, 2023Clin Res Cardiol 2023
Rubini Gimenez Maria, Scheller Bruno, Farah Ahmed, Ohlow Marc-Alexander, Mangner Norman, Weilenmann Daniel, Wöhrle Jochen, Cuculi Florim, Leibundgut Gregor, Möbius-Winkler Sven, Cattaneo Marco, Gilgen Nicole, Kaiser Christoph A, Jeger Raban V
Crystalline sirolimus-coated balloon (cSCB) angioplasty in an all-comers, patient population with stable and unstable coronary artery disease including chronic total occlusions: rationale, methodology and design of the SCORE trial.
Otto S, Díaz V, Weilenmann D, Cuculi F, Nuruddin A, Leibundgut G, Alfonso F, Wan Ahmad W, Pyxaras S, Rittger H, Steen P, Gaede L, Schulze C, Wöhrle J, Rosenberg M, Waliszewski M. Crystalline sirolimus-coated balloon (cSCB) angioplasty in an all-comers, patient population with stable and unstable coronary artery disease including chronic total occlusions: rationale, methodology and design of the SCORE trial. BMC Cardiovasc Disord 2023; 23:176.
Mar 31, 2023Crystalline sirolimus-coated balloon (cSCB) angioplasty in an all-comers, patient population with stable and unstable coronary artery disease including chronic total occlusions: rationale, methodology and design of the SCORE trial.
Mar 31, 2023BMC Cardiovasc Disord 2023; 23:176
Otto Sylvia, Díaz Victor Alfonso Jiménez, Weilenmann Daniel, Cuculi Florim, Nuruddin Amin Ariff, Leibundgut Gregor, Alfonso Fernando, Wan Ahmad Wan Azman, Pyxaras Stylianos, Rittger Harald, Steen Philip, Gaede Luise, Schulze Christian, Wöhrle Jochen, Rosenberg Mark, Waliszewski Matthias W
Impact of Insulin-Treated Compared to Non-Insulin-Treated Diabetes Mellitus on Outcome of Percutaneous Coronary Intervention with Drug-Coated Balloons versus Drug-Eluting Stents in De Novo Coronary Artery Disease: The Randomized BASKET-SMALL 2 Trial.
Seeger J, Wöhrle J, Scheller B, Farah A, Ohlow M, Mangner N, Möbius-Winkler S, Weilenmann D, Stachel G, Leibundgut G, Rickenbacher P, Cattaneo M, Gilgen N, Kaiser C, Jeger R, On Behalf Of The Basket-Small Investigators. Impact of Insulin-Treated Compared to Non-Insulin-Treated Diabetes Mellitus on Outcome of Percutaneous Coronary Intervention with Drug-Coated Balloons versus Drug-Eluting Stents in De Novo Coronary Artery Disease: The Randomized BASKET-SMALL 2 Trial. J Cardiovasc Dev Dis 2023; 10
Mar 13, 2023Impact of Insulin-Treated Compared to Non-Insulin-Treated Diabetes Mellitus on Outcome of Percutaneous Coronary Intervention with Drug-Coated Balloons versus Drug-Eluting Stents in De Novo Coronary Artery Disease: The Randomized BASKET-SMALL 2 Trial.
Mar 13, 2023J Cardiovasc Dev Dis 2023; 10
Seeger Julia, Wöhrle Jochen, Scheller Bruno, Farah Ahmed, Ohlow Marc-Alexander, Mangner Norman, Möbius-Winkler Sven, Weilenmann Daniel, Stachel Georg, Leibundgut Gregor, Rickenbacher Peter, Cattaneo Marco, Gilgen Nicole, Kaiser Christoph A, Jeger Raban V, On Behalf Of The Basket-Small Investigators
Gender differences in percutaneous coronary intervention for chronic total occlusions from the ERCTO study.
Avran A, Zuffi A, Gobbi C, Gasperetti A, Schiavone M, Werner G, Kambis M, Boudou N, Galassi A, Sianos G, Idali M, Garbo R, Gagnor A, Gasparini G, Bufe A, Bryniarski L, Kalnins A, Weilenmann D, Wojcik J, Agostoni P, Bozinovic N, Carlino M, Furkalo S, Hildick-Smith D, Drogoul L, Lemoine J, Serra A, Carugo S, Ungi I, Dens J, Reifart N, Cosma J, Mallia V, Vadalà G, Biondi-Zoccai G, di Mario C. Gender differences in percutaneous coronary intervention for chronic total occlusions from the ERCTO study. Catheter Cardiovasc Interv 2023; 101:918-931.
Mar 8, 2023Gender differences in percutaneous coronary intervention for chronic total occlusions from the ERCTO study.
Mar 8, 2023Catheter Cardiovasc Interv 2023; 101:918-931
Avran Alexandre, Zuffi Andrea, Gobbi Cecilia, Gasperetti Alessio, Schiavone Marco, Werner Gerald S, Kambis Mashayekhi, Boudou Nicolas, Galassi Alfredo R, Sianos George, Idali Moussa, Garbo Roberto, Gagnor Andrea, Gasparini Gabriele, Bufe Alexander, Bryniarski Leszek, Kalnins Artis, Weilenmann Daniel, Wojcik Jaroslaw, Agostoni Pierfrancesco, Bozinovic Nenad Z, Carlino Mauro, Furkalo Sergey, Hildick-Smith David, Drogoul Laurent, Lemoine Julien, Serra Antonio, Carugo Stefano, Ungi Imre, Dens Joseph, Reifart Nicolaus, Cosma Joseph, Mallia Vincenzo, Vadalà Giuseppe, Biondi-Zoccai Giuseppe, di Mario Carlo
Estimated glomerular filtration rate, haemodynamics, and mortality in patients with aortic stenosis.
Appert S, Weber L, Breuss A, Haager P, Joerg L, Weilenmann D, Chronis J, Rigger J, Rickli H, Maeder M. Estimated glomerular filtration rate, haemodynamics, and mortality in patients with aortic stenosis. Eur J Clin Invest 2023:e13965.
Feb 5, 2023Estimated glomerular filtration rate, haemodynamics, and mortality in patients with aortic stenosis.
Feb 5, 2023Eur J Clin Invest 2023:e13965
Appert Sharon, Weber Lukas, Breuss Alexander, Haager Philipp K, Joerg Lucas, Weilenmann Daniel, Chronis Joannis, Rigger Johannes, Rickli Hans, Maeder Micha
Trends in Coronary and Structural Heart Interventions in Switzerland over the Last 16 Years and Impact of COVID-19: Insights from the National Swiss PCI Survey.
Wagener M, Boeddinghaus J, Gaemperli O, Räber L, Nietlispach F, Meier P, Muller O, Weilenmann D, Jeger R. Trends in Coronary and Structural Heart Interventions in Switzerland over the Last 16 Years and Impact of COVID-19: Insights from the National Swiss PCI Survey. J Clin Med 2022; 11
Dec 15, 2022Trends in Coronary and Structural Heart Interventions in Switzerland over the Last 16 Years and Impact of COVID-19: Insights from the National Swiss PCI Survey.
Dec 15, 2022J Clin Med 2022; 11
Wagener Max, Boeddinghaus Jasper, Gaemperli Oliver, Räber Lorenz, Nietlispach Fabian, Meier Pascal, Muller Olivier, Weilenmann Daniel, Jeger Raban
Systemic blood pressure in severe aortic stenosis: Haemodynamic correlates and long-term prognostic impact.
Maeder M, Rickli H, Weber L, Weilenmann D, Ammann P, Joerg L, Haager P, Rigger J, Chronis J, Brenner R. Systemic blood pressure in severe aortic stenosis: Haemodynamic correlates and long-term prognostic impact. ESC Heart Fail 2022; 10:274-283.
Oct 7, 2022Systemic blood pressure in severe aortic stenosis: Haemodynamic correlates and long-term prognostic impact.
Oct 7, 2022ESC Heart Fail 2022; 10:274-283
Maeder Micha, Rickli Hans, Weber Lukas, Weilenmann Daniel, Ammann Peter, Joerg Lucas, Haager Philipp K, Rigger Johannes, Chronis Joannis, Brenner Roman
Drug-Coated Balloon for Small Coronary Artery Disease in Patients With and Without High-Bleeding Risk in the BASKET-SMALL 2 Trial.
Scheller B, Rissanen T, Farah A, Ohlow M, Mangner N, Wöhrle J, Möbius-Winkler S, Weilenmann D, Leibundgut G, Cuculi F, Gilgen N, Coslovsky M, Mahfoud F, Jeger R, BASKET-SMALL 2 Investigators. Drug-Coated Balloon for Small Coronary Artery Disease in Patients With and Without High-Bleeding Risk in the BASKET-SMALL 2 Trial. Circ Cardiovasc Interv 2022; 15:e011569.
Apr 12, 2022Drug-Coated Balloon for Small Coronary Artery Disease in Patients With and Without High-Bleeding Risk in the BASKET-SMALL 2 Trial.
Apr 12, 2022Circ Cardiovasc Interv 2022; 15:e011569
Scheller Bruno, Rissanen Tuomas T, Farah Ahmed, Ohlow Marc-Alexander, Mangner Norman, Wöhrle Jochen, Möbius-Winkler Sven, Weilenmann Daniel, Leibundgut Gregor, Cuculi Florim, Gilgen Nicole, Coslovsky Michael, Mahfoud Felix, Jeger Raban V, BASKET-SMALL 2 Investigators
Drug-coated balloons for small coronary artery disease in patients with chronic kidney disease: a pre-specified analysis of the BASKET-SMALL 2 trial.
Mahfoud F, Farah A, Ohlow M, Mangner N, Wöhrle J, Möbius-Winkler S, Weilenmann D, Leibundgut G, Cuculi F, Gilgen N, Kaiser C, Cattaneo M, Scheller B, Jeger R. Drug-coated balloons for small coronary artery disease in patients with chronic kidney disease: a pre-specified analysis of the BASKET-SMALL 2 trial. Clin Res Cardiol 2022; 111:806-815.
Feb 27, 2022Drug-coated balloons for small coronary artery disease in patients with chronic kidney disease: a pre-specified analysis of the BASKET-SMALL 2 trial.
Feb 27, 2022Clin Res Cardiol 2022; 111:806-815
Mahfoud Felix, Farah Ahmed, Ohlow Marc-Alexander, Mangner Norman, Wöhrle Jochen, Möbius-Winkler Sven, Weilenmann Daniel, Leibundgut Gregor, Cuculi Florim, Gilgen Nicole, Kaiser Christoph, Cattaneo Marco, Scheller Bruno, Jeger Raban V
Safety and Efficacy of Drug-Coated Balloons Versus Drug-Eluting Stents in Acute Coronary Syndromes: A Prespecified Analysis of BASKET-SMALL 2.
Mangner N, Farah A, Ohlow M, Möbius-Winkler S, Weilenmann D, Wöhrle J, Linke A, Stachel G, Markovic S, Leibundgut G, Rickenbacher P, Cattaneo M, Gilgen N, Kaiser C, Scheller B, Jeger R, BASKET-SMALL 2 Investigators. Safety and Efficacy of Drug-Coated Balloons Versus Drug-Eluting Stents in Acute Coronary Syndromes: A Prespecified Analysis of BASKET-SMALL 2. Circ Cardiovasc Interv 2022; 15:e011325.
Jan 10, 2022Safety and Efficacy of Drug-Coated Balloons Versus Drug-Eluting Stents in Acute Coronary Syndromes: A Prespecified Analysis of BASKET-SMALL 2.
Jan 10, 2022Circ Cardiovasc Interv 2022; 15:e011325
Mangner Norman, Farah Ahmed, Ohlow Marc-Alexander, Möbius-Winkler Sven, Weilenmann Daniel, Wöhrle Jochen, Linke Axel, Stachel Georg, Markovic Sinisa, Leibundgut Gregor, Rickenbacher Peter, Cattaneo Marco, Gilgen Nicole, Kaiser Christoph, Scheller Bruno, Jeger Raban V, BASKET-SMALL 2 Investigators
Long-term follow-up of medically treated patients with spontaneous coronary artery dissection: a prospective, Swiss single-centre cohort study
Seidl S, Rigger J, Chronis J, Rohner F, Jörg L, Haager P, Ammann P, Weilenmann D, Rogowski S, Rickli H, Maeder M. Long-term follow-up of medically treated patients with spontaneous coronary artery dissection: a prospective, Swiss single-centre cohort study. Swiss Med Wkly 2021; 151:w30067.
Dec 23, 2021Long-term follow-up of medically treated patients with spontaneous coronary artery dissection: a prospective, Swiss single-centre cohort study
Dec 23, 2021Swiss Med Wkly 2021; 151:w30067
Seidl Sebastian, Rigger Johannes, Chronis Joannis, Rohner Franziska, Jörg Lucas, Haager Philipp K., Ammann Peter, Weilenmann Daniel, Rogowski Sebastian, Rickli Hans, Maeder Micha
Hemodynamics Prior to Valve Replacement for Severe Aortic Stenosis and Pulmonary Hypertension during Long-Term Follow-Up
Weber L, Ehl N, Buser M, Rigger J, Chronis J, Weilenmann D, Jörg L, Haager P, Rickli H, Maeder M. Hemodynamics Prior to Valve Replacement for Severe Aortic Stenosis and Pulmonary Hypertension during Long-Term Follow-Up. J Clin Med 2021; 10
Aug 28, 2021Hemodynamics Prior to Valve Replacement for Severe Aortic Stenosis and Pulmonary Hypertension during Long-Term Follow-Up
Aug 28, 2021J Clin Med 2021; 10
Weber Lukas, Ehl Niklas, Buser Marc, Rigger Johannes, Chronis Joannis, Weilenmann Daniel, Jörg Lucas, Haager Philipp K., Rickli Hans, Maeder Micha
Wedge Pressure vs Left Ventricular End-Diastolic Pressure for Pulmonary Hypertension Classification and Prognostication in Severe Aortic Stenosis
Maeder M, Haager P, Rigger J, Chronis J, Joerg L, Hochholzer D, Weilenmann D, Seidl S, Weber L, Rickli H. Wedge Pressure vs Left Ventricular End-Diastolic Pressure for Pulmonary Hypertension Classification and Prognostication in Severe Aortic Stenosis. CJC Open 2021; 3:1428-1437.
Jul 10, 2021Wedge Pressure vs Left Ventricular End-Diastolic Pressure for Pulmonary Hypertension Classification and Prognostication in Severe Aortic Stenosis
Jul 10, 2021CJC Open 2021; 3:1428-1437
Maeder Micha, Haager Philipp K., Rigger Johannes, Chronis Joannis, Joerg Lucas, Hochholzer David, Weilenmann Daniel, Seidl Sebastian, Weber Lukas, Rickli Hans
Impact of the new pulmonary hypertension definition on long-term mortality in patients with severe aortic stenosis undergoing valve replacement
Maeder M, Schoch O, Neumann T, Brutsche M, Haager P, Pohle S, Joerg L, Chronis J, Weilenmann D, Weber L, Rickli H. Impact of the new pulmonary hypertension definition on long-term mortality in patients with severe aortic stenosis undergoing valve replacement. Clin Cardiol 2021; 44:1276-1285.
Jul 4, 2021Impact of the new pulmonary hypertension definition on long-term mortality in patients with severe aortic stenosis undergoing valve replacement
Jul 4, 2021Clin Cardiol 2021; 44:1276-1285
Maeder Micha, Schoch Otto D, Neumann Thomas, Brutsche Martin, Haager Philipp K, Pohle Susanne, Joerg Lucas, Chronis Joannis, Weilenmann Daniel, Weber Lukas, Rickli Hans
Coronary and structural heart interventions in Switzerland 2019
Wagener M, Jeger R, Weilenmann D, Räber L, Nietlispach F, Muller O, Meier P, Gämperli O, Cook S, Twerenbold R, On Behalf Of The Swiss Working Group Interventional Cardiology Of The Swiss Society Of Cardiology. Coronary and structural heart interventions in Switzerland 2019. Swiss Med Wkly 2021; 151:w20495.
May 11, 2021Coronary and structural heart interventions in Switzerland 2019
May 11, 2021Swiss Med Wkly 2021; 151:w20495
Wagener Max, Jeger Raban, Weilenmann Daniel, Räber Lorenz, Nietlispach Fabian, Muller Olivier, Meier Pascal, Gämperli Oliver, Cook Stéphane, Twerenbold Raphael, On Behalf Of The Swiss Working Group Interventional Cardiology Of The Swiss Society Of Cardiology
Multivessel percutaneous coronary intervention with thin-strut biodegradable versus durable polymer drug-eluting stents in ST-segment elevation myocardial infarction: A subgroup analysis of the BIOSTEMI randomized trial
Iglesias J, Windecker S, Valgimigli M, Heg D, Kaiser C, Weilenmann D, Kurz D, Roffi M, Losdat S, Muller O, Pilgrim T. Multivessel percutaneous coronary intervention with thin-strut biodegradable versus durable polymer drug-eluting stents in ST-segment elevation myocardial infarction: A subgroup analysis of the BIOSTEMI randomized trial. Int J Cardiol 2021; 334:37-41.
Apr 20, 2021Multivessel percutaneous coronary intervention with thin-strut biodegradable versus durable polymer drug-eluting stents in ST-segment elevation myocardial infarction: A subgroup analysis of the BIOSTEMI randomized trial
Apr 20, 2021Int J Cardiol 2021; 334:37-41
Iglesias Juan F, Windecker Stephan, Valgimigli Marco, Heg Dik, Kaiser Christoph, Weilenmann Daniel, Kurz David J, Roffi Marco, Losdat Sylvain, Muller Olivier, Pilgrim Thomas
Five-Year Outcomes With Biodegradable-Polymer Sirolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents in Patients With Acute Coronary Syndrome: A Subgroup Analysis of the BIOSCIENCE Trial
Iglesias J, Windecker S, Jüni P, Valgimigli M, Cuculi F, Kaiser C, Weilenmann D, Cook S, Brinkert M, Muller O, Tüller D, Degrauwe S, Roffi M, Heg D, Pilgrim T. Five-Year Outcomes With Biodegradable-Polymer Sirolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents in Patients With Acute Coronary Syndrome: A Subgroup Analysis of the BIOSCIENCE Trial. Cardiovasc Revasc Med 2021; 34:3-10.
Feb 25, 2021Five-Year Outcomes With Biodegradable-Polymer Sirolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents in Patients With Acute Coronary Syndrome: A Subgroup Analysis of the BIOSCIENCE Trial
Feb 25, 2021Cardiovasc Revasc Med 2021; 34:3-10
Iglesias Juan F, Windecker Stephan, Jüni Peter, Valgimigli Marco, Cuculi Florim, Kaiser Christoph, Weilenmann Daniel, Cook Stéphane, Brinkert Miriam, Muller Olivier, Tüller David, Degrauwe Sophie, Roffi Marco, Heg Dik, Pilgrim Thomas